Wednesday, February 10, 2010, 4:30am EST - Canadian Markets open in 5 hours.
To create a watchlist or portfolio of shares, Sign-in or Register

Eli Lilly & Co. (LLY)

On Feb 9: 35.20 USD   0.00 (0.00%)  
MORE ON LLY
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Tue, Feb 9, 2010
Researchers find sex-specific lung cancer genes
at Reuters (Tue 7:34pm)
UK court overturns GSK patent for lupus drug
at FT.com (Tue 6:10pm)
Bone Up On This Potential Blockbuster
at Motley Fool (Tue 11:58am)
UK court rules HGS gene patent invalid -lawyers
at Reuters (Tue 11:39am)
Four Stock Ideas as the Market Searches for Support
at Seeking Alpha (Tue 9:56am)
Health Care: Rx for MBA Job Blues
BusinessWeek (Tue 8:08am)
Mon, Feb 8, 2010
Lechleiter pay rises in 1st full year as Lilly CEO
AP (Mon, Feb 8)
Eli Lilly CEO's 2009 Compensation Totaled $16.4 Million
at The Wall Street Journal Online (Mon, Feb 8)
Alkermes Retains Neutral Rec
Zacks.com (Mon, Feb 8)
Sun, Feb 7, 2010
[$$] Sanofi to decide soon on reviving Merck venture
at The Wall Street Journal Online (Sun, Feb 7)
How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
Sat, Feb 6, 2010
[$$] Research Reports
at Barrons.com (Sat, Feb 6)
Fri, Feb 5, 2010
What Is The Value Of An Employee
at Investopedia (Fri, Feb 5)
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times (Fri, Feb 5)
Ahead of the Bell: Alkermes upgraded on 3Q results
AP (Fri, Feb 5)
Thu, Feb 4, 2010
Miss. settles Zyprexa suit for more than $18M
AP (Thu, Feb 4)
Surfing the Wave of the Future: Personalized Medicine
at Motley Fool (Thu, Feb 4)
Pfizer Feeling Frisky
at Investopedia (Thu, Feb 4)
Alkermes Testing its Version of Popular Schizophrenia Drug
at TheStreet.com (Thu, Feb 4)
Alkermes Testing Schizophrenia Drug
at TheStreet.com (Thu, Feb 4)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices